Brieuc S.
- Country
- Belgium
- Department
- Medical Oncology
Research Overview
- A Phase 2, Randomized, Open-Label Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-Resistant Prostate Cancer (TAMARACK)
- Phase 3 Study of Enfortumab Vedotin and Pembrolizumab Versus Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer
- Evaluation of Lorigerlimab and Docetaxel Versus Docetaxel Monotherapy in Metastatic Castration-Resistant Prostate Cancer Patients
Data & Insights
Has run more than one trial at 88 of 236 partner sites.
Specializations
Prostate Cancer Research
The investigator specializes in advanced therapeutic approaches for prostate cancer, with particular emphasis on both metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).
- Biomarker-driven treatment strategies
- Novel therapeutic combinations
- Treatment intensification protocols
Research includes evaluation of innovative treatment modalities incorporating molecular diagnostics and targeted therapies.
Colorectal Cancer Studies
Focus on treating KRAS/NRAS and BRAF wild-type colorectal cancer, particularly investigating therapeutic approaches for unresectable and metastatic disease.
- Left-sided colorectal cancer treatments
- Targeted therapy combinations
- Recurrent disease management
Investigation of novel therapeutic combinations for both treatment-naïve and recurrent cases.
Urological Oncology
Expertise in treating various forms of urological cancers, with special focus on muscle-invasive bladder cancer and advanced urothelial cancer.
- Neoadjuvant treatment protocols
- Immunotherapy combinations
- Advanced bladder cancer management
Research encompasses both early-stage interventions and treatment strategies for advanced disease states.
Head and Neck Oncology
Investigation of innovative treatments for head and neck squamous cell carcinoma (HNSCC), focusing on advanced and metastatic disease states.
- Immunotherapy approaches
- Combination therapy evaluation
- Response assessment protocols
Development of novel therapeutic strategies for metastatic HNSCC management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.